Population ageing in Africa will increase the burden of Alzheimer's disease and related dementias within the next few decades. Despite the potential for discovery of novel genetic risks in African populations, there is still a paucity of dementia genetic research among indigenous Africans.
Objective
We aimed to investigate the knowledge and attitudes of elderly population in Nigeria about dementia and dementia genetics.
Methods
One hundred clinic attendees (aged ≥60 years) recruited at the University College Hospital, Ibadan, Nigeria were surveyed using an interviewer-administered questionnaire consisting of the Dementia Knowledge Assessment Scale (DKAS) and other items assessing knowledge and attitudes about dementia genetics.
Results
The mean age (±SD) of participants was 71.0 (±7.1) years, and the mean (±SD) DKAS score was 8.87 (±10.84). Only 10% were considered to have good knowledge of dementia (i.e., DKAS score ≥26). Attempts by participants to translate “dementia” in their local languages revealed misleading themes in their perception of the condition. Of the 42 participants who claimed to know what dementia is, 32 (76.2%) of them had poor knowledge (i.e., DKAS <26). Twenty-one participants were aware of the existence of genetic risk factors for dementia, but none could name a dementia risk gene. Seventy participants expressed willingness to undergo genetic testing to assess their risk of dementia.
Conclusions
There is a poor level of knowledge about dementia and dementia genetics among the elderly population in Nigeria. Public health education and community engagement is important for maximizing the impact of dementia genetic studies in Africa.
NicholsESteinmetzJDVollsetSE, et al.Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health2022; 7: e105–e125.
2.
AkinyemiROYariaJOjagbemiA, et al.Dementia in Africa: current evidence, knowledge gaps, and future directions. Alzheimers Dement2022; 18: 790–809.
3.
PrinceMJAcostaDCastro-CostaE, et al.Packages of care for dementia in low- and middle-income countries. PLoS Med2009; 6: e1000176.
4.
AdeloyeDAutaAEzejimoforM, et al.Prevalence of dementia in Nigeria: a systematic review of the evidence. J Glob Health Rep2019; 3: e2019014.
5.
George-CareyRAdeloyeDChanKY, et al.An estimate of the prevalence of dementia in Africa: a systematic analysis. J Glob Health2012; 2: 020401.
6.
FerrariRHernandezDGNallsMA, et al.Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol2014; 13: 686–699.
7.
GuoPGongWLiY, et al.Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer’s disease and Parkinson’s disease: a large-scale multi-trait association analysis. BMC Med2022; 20: 214.
8.
BellenguezCKüçükaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet2022; 54: 412–436.
9.
ZhangJWangYZhangY, et al.Genome-wide association study in Alzheimer’s disease: a bibliometric and visualization analysis. Front Aging Neurosci2023; 15: 1290657.
10.
ChiaRSabirMSBandres-CigaS, et al.Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet2021; 53: 294–303.
11.
JonsonCLevineKSLakeJ, et al.Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature. Alzheimers Dement2024; 20: 5740–5756.
12.
FitipaldiHFranksPW. Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005–2022. Hum Mol Genet2023; 32: 520–532.
13.
AndrewsSJRentonAEFulton-HowardB, et al.The complex genetic architecture of Alzheimer’s disease: novel insights and future directions. eBioMedicine2023; 90: 104511.
14.
CampbellMCTishkoffSA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet2008; 9: 403–433.
15.
CaliebeATekola-AyeleFDarstBF, et al.Including diverse and admixed populations in genetic epidemiology research. Genet Epidemiol2022; 46: 347–371.
16.
The Lancet Neurology. Increasing diversity in dementia research. Lancet Neurol2023; 22: 1.
17.
McGuireALGabrielSTishkoffSA, et al.The road ahead in genetics and genomics. Nat Rev Genet2020; 21: 581–596.
18.
HouYDanXBabbarM, et al.Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol2019; 15: 565–581.
19.
WahlDSolon-BietSMCoggerVC, et al.Aging, lifestyle and dementia. Neurobiol Dis2019; 130: 104481.
20.
GuerreiroRBrasJ. The age factor in Alzheimer’s disease. Genome Med2015; 7: 106.
21.
AkinyemiROOwolabiMOOkubadejoN, et al.The African Dementia Consortium. Lancet Neurol2023; 22: 28–29.
22.
PrinceMAcostaDFerriCP, et al.A brief dementia screener suitable for use by non-specialists in resource poor settings–the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia. Int J Geriatr Psychiatry2011; 26: 899–907.
23.
AnnearMJToyeCElliottK-EJ, et al.Dementia knowledge assessment scale (DKAS): confirmatory factor analysis and comparative subscale scores among an international cohort. BMC Geriatr2017; 17: 168.
24.
SungH-CSuH-FWangH-M, et al.Psychometric properties of the dementia knowledge assessment scale-traditional Chinese among home care workers in Taiwan. BMC Psychiatry2021; 21: 515.
25.
YusufAJBaiyewuO. Beliefs and attitudes towards dementia among community leaders in northern Nigeria. West Afr J Med2012; 31: 8–13.
26.
AdebiyiAOFagbolaMAOlakehindeO, et al.Enacted and implied stigma for dementia in a community in south-west Nigeria. Psychogeriatrics2016; 16: 268–273.
27.
MusyimiCWNdeteiDMEvans-LackoS, et al.Perceptions and experiences of dementia and its care in rural Kenya. Dementia2021; 20: 2802–2819.
28.
MusokePOlumRKembabaziS, et al.Assessment of the knowledge and attitude towards dementia among undergraduate university students in Uganda. Adv Med Educ Pract2021; 12: 635–646.
29.
SpittelSKrausEMaierA. Dementia awareness challenges in Sub-Saharan Africa: a cross-sectional survey conducted among school students in Ghana. Am J Alzheimers Dis Demen2021; 36: 15333175211055315.
30.
TegegneMDYilmaTMMelakuMS, et al.Health information seeking and its associated factors in Ethiopia: systematic review and meta-analysis. Inform Med Unlocked2022; 31: 100980.
31.
KateyDAgyekumAMorganAK. Improving health-seeking behaviours of older adults in urban Africa: a holistic approach and strategic initiatives. J Glob Health2024; 14: 03009.
32.
AbdulraheemIS. Health needs assessment and determinants of health-seeking behaviour among elderly Nigerians: a house-hold survey. Ann Afr Med2007; 6: 58–63.
33.
AdewoyeKRAremuSKEkpoDS, et al.Health-seeking behavioural practices of the elderly in rural community of Ekiti State, Southwestern Nigeria. Niger J Med2023; 32: 251.
34.
NwakasiCCde MedeirosKBosun-ArijeFS. “We are doing these things so that people will not laugh at us”: caregivers’ attitudes about dementia and caregiving in Nigeria. Qual Health Res2021; 31: 1448–1458.
35.
AldharmanSSAlayedFTAljohaniBS, et al.An assessment of dementia knowledge and its associated factors among health college students in Saudi Arabia. Cureus2023; 15: e34578.
36.
SierraC. Hypertension and the risk of dementia. Front Cardiovasc Med2020; 7: 5.
37.
NagarSDPemuPQianJ, et al.Investigation of hypertension and type 2 diabetes as risk factors for dementia in the all of us cohort. Sci Rep2022; 12: 19797.
38.
AlsharifAAWeiLMaT, et al.Prevalence and incidence of dementia in people with diabetes mellitus. J Alzheimers Dis2020; 75: 607–615.
39.
CholertonBBakerLDMontineTJ, et al.Type 2 diabetes, cognition, and dementia in older adults: toward a precision health approach. Diabetes Spectr2016; 29: 210–219.
40.
JayarajRLAzimullahSBeiramR. Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci2020; 27: 736–750.
41.
LoJWCrawfordJDSamarasK, et al.Association of prediabetes and type 2 diabetes with cognitive function after stroke. Stroke2020; 51: 1640–1646.
42.
RasmussenJLangermanH. Alzheimer’s disease – Why we need early diagnosis. Degener Neurol Neuromuscul Dis2019; 9: 123–130.
43.
EpsteinELKoleR. The language of African literature. Trenton, NJ: Africa World Press, 1998.
GuerchetMMaystonRLloyd-SherlockP, et al.Dementia in sub-Saharan Africa: Challenges and opportunities. London, UK: Alzheimer’s Disease International, 1 September 2017.
46.
MfeneXPPillayBJ. Dementia-friendly communities: exploring terms used to describe dementia, attitudes and reactions towards people with dementia in Ilembe District, South Africa. Dementia2023; 22: 964–977.
47.
KadmiriNEZaidNZaidY, et al.Novel presenilin mutations within Moroccan patients with early-onset Alzheimer’s disease. Neuroscience2014; 269: 215–222.
48.
HeckmannJMLowW-Cde VilliersC, et al.Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer’s disease. Brain2004; 127: 133–142.
49.
AkinyemiROOwolabiMOMakanjuolaVA, et al.Frontotemporal dementia in a Nigerian woman: case report and brief review of the literature. Afr J Med Med Sci2009; 38: 71–75.
50.
YusufAJBaiyewuOSheikhTL, et al.Prevalence of dementia and dementia subtypes among community-dwelling elderly people in northern Nigeria. Int Psychogeriatr2011; 23: 379–386.
51.
FriedmanDBBecofskyKAndersonLA, et al.Public perceptions about risk and protective factors for cognitive health and impairment: a review of the literature. Int Psychogeriatr2015; 27: 1263–1275.
52.
HippsYGRobertsJSFarrerLA, et al.Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer’s disease. Genet Test2003; 7: 39–44.
53.
MoscarilloTJHoltHPermanM, et al.Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups. Community Genet2007; 10: 97–102.
54.
AkinleyeIRobertsJSRoyalCDM, et al.Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer’s disease. J Genet Couns2011; 20: 650–659.
55.
RajabliFBeechamGWHendrieHC, et al.A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s disease in African Ancestry. PLoS Genet2022; 18: e1009977.
56.
RyanMMCoxCGWitbrachtM, et al.Using direct-to-consumer genetic testing results to accelerate Alzheimer’s disease clinical trial recruitment. Alzheimer Dis Assoc Disord2021; 35: 141–147.
RajabliFFelicianoBECelisK, et al.Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet2018; 14: e1007791.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
